跳至主要内容
临床试验/NCT00913042
NCT00913042已完成不适用

Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2008年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
proportion of microbiologically documented infections

研究概览

简要总结

Febrile neutropenia are microbiologically documented in only 30% of the cases, and almost exclusively by blood cultures. The reasons for this low documentation are likely multiple: (1) some of these fevers are of non-infectious origin. (2) The bacterial inoculum present in the blood may be low and consequently undetectable by conventional blood cultures.

The primary objective of the study is to assess new blood culture procedures and technics, in order to improve the diagnostic yield of blood cultures during febrile neutropenic episodes.

详细描述

Evaluation criteria are 1) proportion of microbiologically documented infections 2) time elapsed from bed side sampling to microbiological diagnostic, in case of positive sample.

The assessed procedures included a large volume of blood, an early incubation made possible by the availability of a culture device in the hematology department, an early warning in case of positive blood culture, bacterial DNA detection in blood, and an early identification of the positive strains and their resistance profile.

We hypothesize that the combination of these different procedures will improve the proportion of microbiologically blood culture from 30 to 45%. One hundred and 20 episodes of febrile neutropenia are necessary to achieve this goal.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 18 y
  • first episode of febrile neutropenia during a given neutropenic phase
  • PMN < 500/mm3, chemotherapy-induced
  • fever > 38°C twice, or < 38°3C once
  • signed informed consent

排除标准

  • patient already receiving empirical or therapeutic antibacterial after their first episode of febrile neutropenia

结局指标

主要结局

proportion of microbiologically documented infections

时间窗: Day 14 from inclusion

次要结局

  • clinical status at the end of hospitalisation(Day 30 from inclusion)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验